CVAC

CureVac N.V.

3.67 USD
0.00 (0.00%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

CureVac N.V. stock is up 5.46% since 30 days ago. The next earnings date is Jun 25, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 25% of the previous 3 June’s closed higher than May. In the last 2 Unusual Options Trades, there were 1 CALL, 1 PUT.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 May 19:17 18 Oct, 2024 5.00 CALL 403 278
07 Jun 14:51 19 Jul, 2024 2.50 PUT 3000 2392

About CureVac N.V.

CureVac N.V. focuses on developing various transformative medicines based on messenger ribonucleic acid (mRNA) It is developing prophylactic vaccines, such as mRNA-based vaccine candidates CV2CoV and CV7202. The company also develops RNA-based cancer immunotherapies, including CV8102, which is in Phase 1 clinical trial for treating cutaneous melanoma and adenoidcystic carcinoma.